Aminoleban Injection 500Ml
AMINOLEBAN normalized the pattern of free amino acids in the plasma and brain, improved serotonin metabolism in the...
AMINOLEBAN normalized the pattern of free amino acids in the plasma and brain, improved serotonin metabolism in the brain and corrected a sleep-wakefulness pattern in a rat model of chronic hepatic insufficiency which underwent a portacaval shunt operation. 2. When infused to portacaval-shunted rats loaded with ammonia, AMINOLEBAN improved EEG pattern and corrected amine metabolism in the brain as evidenced by correction of the free amino acid pattern in the plasma and brain and by suppression of an increase of the false neurotransmitter octopamine.
Purpose
Liver Disorder
Ingredients
Aminoacetic acid 9g, L-alanine 7.5g, L-arginine HCl 7.3g, L-arginine 6g, L-cysteine HCl monohydrate 0.4g, L-cysteine 0.3g, L-histidine HCl monohydrate 3.2g, L-histidine 2.4g, L-isoleucine 9g, L-leucine 11g, L-Lysine HCl 7.6g, L-lysine 6.1 g, L-methionine 1g, L-phenylalanine 1g, L-proline 8g, L-serine 5g, L-threonine 4.5g, L-tryptophan 0.7g, L-valine 8.4g
Warnings
AMINOLEBAN Infusion is advised to be administered with caution in Patients with severe acidosis (The patient’s clinical condition may be worsened.)
AMINOLEBAN Infusion is advised to be administered with caution in Patients with congestive cardiac failure (An increase in the circulating blood volume may worsen the patient’s clinical condition.)
AMINOLEBAN Infusion is advised to be administered with caution Patients on dialysis or hemofiltration with serious renal disorder .
Side Effects
1) Clinically significant adverse reactions: (1) Hypoglycemia: Hypoglycemia may occur. If the patient develops hypoglycemia, glucose should be administered promptly by intravenous infusion. In addition, appropriate nutrition management is required in such patients. (2) Hyperammonemia: Hyperammonemia has been reported. If the patient develops persistent hyperammonemia during the administration of AMINOLEBAN®,discontinue administration and take measures to eliminate other nitrogen sources.2) Other adverse reactions : (1) Hypersensitivity : Symptoms such as skin rash may occur rarely. In the event of skin rash, discontinue the administration and institute appropriate treatment. (2) Gastrointestinal : Symptoms such as nausea and vomiting may occur infrequently. (3) Cardiovascular : Symptoms such as chest discomfort and palpitation may occur infrequently. (4) Metabolic : The nitrogen content of this preparation may induce a transient increase in blood ammonia concentrations. (5) Large dose and rapid administration : Acidosis may occur when large doses are administered rapidly.(6) Others : Chills, fever, headache and vascular pain may infrequently occur.
Storage Instructions
Store this medicine at room temperature, away from direct light and heat.
| Brand | Otsuka PAK |
| Status | Active |
Related Products
